Financial News

Cellenkos raises $15M Series A for platform targeting treatments for autoimmune, inflammatory disases

Cellenkos was founded by Dr. Simrit Parmar, an associate professor in the lymphoma and myeloma department at M.D. Anderson Cancer Center.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback